vTv Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $-123.5M | $45.2M |
| Jun 2017 | — | $-106.4M | $32.5M |
| Sep 2017 | — | $-136.3M | $20.5M |
| Dec 2017 | — | $-151.0M | $11.8M |
| Mar 2018 | — | $-148.8M | $6.5M |
| Jun 2018 | — | $-71.6M | $1.2M |
| Sep 2018 | — | $-44.0M | $3.8M |
| Dec 2018 | $15.1M | $-82.9M | $1.7M |
| Mar 2019 | — | $-57.7M | $5.0M |
| Jun 2019 | — | $-49.9M | $1.5M |
| Sep 2019 | — | $-47.1M | $2.4M |
| Dec 2019 | $5.0M | $-49.0M | $1.8M |
| Mar 2020 | — | $-61.8M | $406.0K |
| Jun 2020 | — | $-69.5M | $6.4M |
| Sep 2020 | — | $-51.4M | $1.8M |
| Dec 2020 | — | $-80.1M | $5.7M |
| Mar 2021 | — | $-56.3M | $8.4M |
| Jun 2021 | — | $-47.8M | $10.8M |
| Sep 2021 | — | $-21.5M | $19.6M |
| Dec 2021 | — | $-9.7M | $13.4M |
| Mar 2022 | — | $-8.1M | $12.1M |
| Jun 2022 | — | $-8.5M | $17.9M |
| Sep 2022 | — | $-16.6M | $15.3M |
| Dec 2022 | — | $-10.7M | $12.1M |
| Mar 2023 | — | $-19.2M | $18.8M |
| Jun 2023 | — | $-25.3M | $12.6M |
| Sep 2023 | — | $-25.2M | $8.2M |
| Dec 2023 | — | $-24.7M | $9.4M |
| Mar 2024 | — | $20.8M | $52.3M |
| Jun 2024 | — | $16.5M | $45.5M |
| Sep 2024 | — | $15.0M | $41.6M |
| Dec 2024 | — | $12.2M | $36.7M |
| Mar 2025 | — | $7.9M | $31.1M |
| Jun 2025 | — | $2.8M | $25.9M |
| Sep 2025 | — | $70.5M | $98.5M |
| Dec 2025 | — | $64.4M | $88.9M |
| Mar 2026 | — | $90.0M | $98.1M |
| Jun 2026 | — | $78.6M | $86.6M |